MAGNESIUMSULFAT 50% Inresa Conc.for Inj./Inf.L., 10X10 ml

Instructions for use for MAGNESIUMSULFAT 50% Inresa Conc.for Inj./Inf.L., 10X10 ml

Directions for use of the article Magnesium Sulphate 50% Inresa Infusion Solution Conc. Important information (compulsory information): Magnesium sulphate 50% Inresa Concentrate for the preparation of a solution for injection or infusion. Indications: For pre-eclampsia, eclampsia. Indications Pre-eclampsia, eclampsia Contraindications Severe bradycardia, myasthenia gravis, AV-block or other cardiac conduction disorders, severe renal dysfunction, anuria, exsiccosis, calcium magnesium ammonium phosphate stones. Mg 50% Inresa should not be used concomitantly with barbiturates, narcotics or hypnotics. Side effects Very common: flushing Frequent: nausea or vomiting, muscle weakness, absent or reduced tendon reflexes, respiratory depression, injection site reactions (pain, burning, swelling, inflammation). Occasional: thirst, headache; hypotension, cardiac palpitations, tachycardia; dizziness, drowsiness or confusion, itching or tingling Also may occur: Skin rash, hyperkalaemia, prolonged bleeding time and visual disturbances. Composition 1 ampoule of 10 ml contains: Active substance: 5.0 g magnesium sulphate heptahydrate, corresponding to 493 mg magnesium ions (corresponding to 20.25 mmol Mg). Instructions for use The application should only be carried out by qualified personnel. The duration of use is determined by the doctor. In case of overdose, contact a doctor immediately. Contraindications AV-Contraindications are hypersensitivity to the ingredients, AV-block, cardiac conduction disorders, nervous disorders, impaired kidney function, tendency to form kidney stones, slow pulse, absence of urine output and dehydration. In pregnancy and lactation, a doctor should be consulted before use. Side effects Possible side effects are slow pulse, drop in blood pressure, impaired conduction of excitation in the heart, vomiting, nausea, headache, dizziness, restlessness, dry mouth, tingling, sweating, agitation, tremor, breathing difficulties, low blood pressure, reactions at the injection site, thirst, palpitations, drowsiness, confusion, itching, skin rash, increased potassium in the blood, prolonged bleeding time and visual disturbances. Important information The medicinal product should be stored away from heat. After opening/preparation, the medicinal product is intended for single use only. Manufacturer: Inresa Arzneimittel GmbH, Obere Hardtstraße 18, 79114 Freiburg, Germany